Late Stage Investors & VC Firms in Belgium
49 firms in this list, with a median first check of $1M. 11 of them lead rounds. Generated from verified public data and updated continuously.
Meusinvest (Noshaq)
LiegeSeed–Late Stage
71 people
Atomico
LondonSeed–Late Stage
49 people
Capricorn Venture Partners
LeuvenSeed–Late Stage$270K – $10.8M
30 people
b2venture
BerlinPre-Seed–Late Stage$270K – $5.4M
36 people
Korys
HalleSeries A–Late Stage$5.4M
32 people
EQT Life Sciences
LuxembourgSeed–Late Stage$11M – $66M
39 people
Karista
ParisPre-Seed–Late Stage$324K – $5.4M
14 people
PMV
BrusselsPre-Seed–Late Stage
1 person
McWin Capital Partners
LondonSeries B–Late Stage
31 people
SmartFin
BrusselsSeed–Late Stage$1.1M – $55M
23 people
European Circular Bioeconomy Fund
BonnSeries A–Late Stage$5.5M – $16.5M
24 people
Newion
AmsterdamSeed–Late Stage$1.1M – $11M
15 people
BioGeneration Ventures
NaardenPre-Seed–Late Stage
27 people
Isomer Capital
LondonSeed–Late Stage
20 people
Gilde Healthcare
UtrechtSeed–Late Stage$1.1M – $55M
24 people
M80 Partners
BrusselsGrowth–Late Stage$11M – $66M
16 people
Limburgse Reconversie Maatschappij
HasseltSeed–Late Stage$27K – $10.8M
22 people
Verlinvest
BrusselsSeed–Late Stage
13 people
Motive Partners
New YorkPre-Seed–Late Stage$1M – $10M
2 people
Bioqube Ventures
BrusselsPre-Seed–Late Stage$108K – $6.5M
19 people
German Media Pool
BerlinSeed–Late Stage$550K – $5.5M
7 people
Debiopharm Innovation Fund
LausannePre-Seed–Late Stage$1M – $5M
13 people
Senovo
MunichSeed–Late Stage$1.1M – $5.4M
6 people
Vendis Capital
DiegemGrowth–Late Stage$5.4M – $81M
15 people
Related lists
Seed Investors & VC Firms (10665)Series A Investors & VC Firms (7875)Pre-Seed Investors & VC Firms (5679)Investors & VC Firms in United States (5050)Growth Investors & VC Firms (4757)Series B Investors & VC Firms (4094)Investors & VC Firms in Global (4044)Seed Investors & VC Firms in United States (3953)Series A Investors & VC Firms in United States (3337)Late Stage Investors & VC Firms (2864)
Data sourced from public filings and firms' own websites — see our methodology.













































































